BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36440844)

  • 1. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma.
    Wang J; Wu L; Lu W; Zhang H; Wu Y
    Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway.
    Chen C; Shen Z
    Protein Pept Lett; 2023; 30(1):54-64. PubMed ID: 36278453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
    Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
    Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
    Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
    J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
    Lu JC; Zhang YP
    Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 12. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network.
    Gong Y; Xu F; Deng L; Peng L
    Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Identification of Three Key Genes Related to Stemness in Thyroid Carcinoma through Comprehensive Analysis.
    Zhang T; Yan C; Ye Z; Yin X; Jiang TA
    Comb Chem High Throughput Screen; 2021; 24(3):423-432. PubMed ID: 32767928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer.
    Zhao H; Zhang S; Shao S; Fang H
    Front Endocrinol (Lausanne); 2020; 11():510. PubMed ID: 32849296
    [No Abstract]   [Full Text] [Related]  

  • 15. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 20. Identifying key genes of classic papillary thyroid cancer in women aged more than 55 years old using bioinformatics analysis.
    Li CC; Ullah MHE; Lin X; Shan SK; Guo B; Zheng MH; Wang Y; Li F; Yuan LQ
    Front Endocrinol (Lausanne); 2022; 13():948285. PubMed ID: 36120433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.